Antonella Riva

This inventor holds 17 USPTO granted patents and 6 published patent applications, plus 7 CIPO patents and 11 EPO patents, primarily in Pharmaceutical Compositions. Top assignee: Indena S.p.a.. Active years: 2006-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Antonella Riva. Retrieved from https://idiyas.com/inventor/antonella-riva

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 6)

% Patents Active = 29.4

CIPO Patents = 7 (Patent Applications = 5)

EPO Patents = 11 (Patent Applications = 13)

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 93(Granted Patents)

Company Filing History:

17 out of 216

Indena S.p.a.

patents

Years Active: 2006-2026

Loading Chart...

Areas of Expertise:

Hyperforin Derivatives

Antitumoral Agents

Sanguinarine

Cholesterol Homeostasis

Isothiocyanate Derivatives

Quercetin

Oral Cavity Infections

Benzophenanthridine Structure

TRPV1 Agonists

Berberine

Powder Solid Dispersions

Formulations

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12673079 - Compositions comprising an American cranberry extract and phospholipids (2026-07-07),

2. 11786513 - Compositions comprising berberine (2023-10-17),

3. 11331298 - Powder solid dispersions comprising quercetin, process for their preparation and formulations thereof (2022-05-17),

4. 9556099 - Hyperforin derivatives and their use in Alzheimer's disease (2017-01-31),

5. 9393280 - Formulations with sanguinarine, chelerythrine or chelidonine for the treatment of warts, verrucas and psoriatic plaques (2016-07-19),

6. 8772251 - Use of isothiocyanate derivatives as anti-myeloma agents (2014-07-08),

7. 8569455 - Cloning, yeast expression, purification and biological activity of the extension region of the soybean 7S globulin alfa' subunit involved in HEP G2 cell cholesterol homeostasis (2013-10-29),

8. 8496975 - Compositions for the treatment and prevention of infections of the oral cavity (2013-07-30),

9. 8337903 - Antitumoral agents with a benzophenanthridine structure and formulations containing them (2012-12-25),

10. 8226994 - Formulations with sanguinarine, chelerythrine or chelidonine for the treatment of warts, verrucas and psoriatic plaques (2012-07-24),

11. RE43280 - Hyperforin derivatives, the use thereof and formulations containing them (2012-03-26),

12. 7438934 - Formulations useful in the treatment of male and female impotence (2008-10-21),

13. 7429673 - TRPV1 agonists, formulations containing them and uses thereof (2008-09-30),

14. 7361370 - Formulations useful in the treatment of male and female impotence (2008-04-22),

15. 7128932 - Formulations useful in the treatment of male and female impotence (2006-10-31),

Title: Celebrating Innovator Antonella Riva: A Trailblazer in Pharmaceutical Compositions

Introduction: Antonella Riva, based in Milan, Italy, is a distinguished inventor with an impressive portfolio of 16 patents. Her work primarily focuses on innovative compositions that harness the power of natural substances for various applications in pharmaceuticals, nutraceuticals, and cosmetics.

Latest Patents: Antonella's latest contributions to the field include groundbreaking patents such as "Compositions comprising berberine" and "Powder solid dispersions comprising quercetin, process for their preparation and formulations thereof." The first patent discloses formulations that combine berberine with pea proteins and surfactants, offering potential enhancements in bioavailability and efficacy. The second patent features powder solid dispersions that incorporate quercetin and phospholipids, along with a highly water-soluble carrier, revealing new possibilities for pharmaceutical and cosmetic compositions.

Career Highlights: As a key contributor at Indena S.p.A., Antonella Riva has played a vital role in advancing the company's mission to innovate within the field of natural ingredients. Her unwavering commitment to research and development has not only led to her numerous patents but has also positioned her as a leader in the industry.

Collaborations: Throughout her career, Antonella has collaborated with esteemed colleagues, including Paolo Morazzoni and Ezio Bombardelli. These partnerships have fostered a dynamic exchange of ideas and expertise, significantly enhancing the quality and impact of their collective work in product innovation.

Conclusion: Antonella Riva's pioneering spirit and dedication to improving health and wellness through innovative compositions make her a remarkable figure in the realm of inventions. Her patents not only reflect her ingenuity but also contribute significantly to the advancement of science and technology in the pharmaceutical sector. As the industry continues to evolve, Antonella’s work stands as a testament to the importance of innovation in enhancing human health.

Profile summary based on public USPTO records.